June 28, 2012—The U.S. Supreme Court’s 5-to-4 decision today to largely uphold the constitutionality of the Affordable Care Act (ACA) preserves rural, children’s, and cancer hospitals’ eligibility to participate in the 340B drug discount program. The Drug Discount Monitor is still analyzing the 193-page decision.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)